chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A Series of patients aprox 540 patients received past its 30 days expired date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A Series of patients aprox 540 patients received past its 30 days expired date.) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H71A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2022 at 2:59 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 18-Mar-2022 at 2:59 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (A Series of patients aprox 540 patients received past its 30 days expired date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A Series of patients aprox 540 patients received past its 30 days expired date.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.  A Series of patients approx. 540 patients received lot number 066H71A past its 30 days expired date. Vaccines went into 2-8 degree Celsius thaw state on or above 24-Dec-2021. This vaccine was administered up until its Mfg Exp date of 04-Apr-2022.
adverse reaction started within 1-2 days of second dose of vax: severe fatigue and dyspnea on exertion of walking 10-15 feet, dyspnea, severe arthralgias refractory to NSAIDS and opiates and tylenol) mainly in neck, shoulders, upper back and arms
Narrative:  PATIENT REPORTS LEFT LEG SWELLING SINCE VACCINE ON 4/21/21 TO CURRENT.
Metallic taste in mouth Body aches fatigue arm and fingers burned like it was nerve pain armpits hurt  swollen lymph nodes tingling on the left side of her face
Lymphedema on both legs; This is a spontaneous report received from contactable reporter(s) (Other HCP and Physician).  A 69-year-old female patient received BNT162b2 (BNT162B2), on 09Oct2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 69 years for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "kidney disease" (unspecified if ongoing), notes: I was saying she also has kidney disease. I do not know exactly. The patient took concomitant medications. The following information was reported: LYMPHOEDEMA (non-serious) with onset 01Apr2022, outcome "unknown", described as "Lymphedema on both legs". Therapeutic measures were not taken as a result of lymphoedema.  Additional Information: Reporter stated, " not sure if she have that. Expiry Date of Covid 19 Vaccine: Unknown. Additional Context: Last Name: "(last name withheld)" (Not clarified appropriately. Hence, captured as unknown in tab). Concern: Reporter stated, "she is calling in behalf of the provider Doctor (last name withheld), he wants to report a side effect from the vaccine." Reporter confirmed the product name as Pfizer COVID 19 Vaccine. When probed for adverse event, reporter stated, "So, it was Lymphedema on both legs." Specialty of the Doctor: Reporter stated, "Internal medicine. Reporter was informed about role of Pfizer drug safety department. "The height is 59.5 inches, 59.5 inches. "  Reporter stated, Date of administration: It would be 09Oct2021. Start date of adverse event: Reporter stated, "I think she came to the office but I am not sure, hold on. Okay we can predict as 01Apr of this year." Medical Condition: Reporter stated, "She had hypertension. And kidney disease, would that come in as well. I was saying she also has kidney disease. I do not know exactly." Concomitant: Reporter stated, "Yes, taking a couple. No Lab Test: Reporter stated, "Last two weeks. No Treatment of adverse event.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Information has been received on 18-SEP-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 13-DEC-2013, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other related complications. On or about 07-NOV-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Patient presented to medical facility in respiratory distress.  Reportedly "feeling poorly"  since 8/17/2021.  Upon arrival in the emergency department his oxygen saturations were in the upper 80s.  He became more tachypneic with respiratory rates near 60, he was tachycardic and hypertensive.  A brief trial of Bipap failed and patient required intubation.  He tested positive for COVID-19 infection and required ICU admission. The patient is currently admitted with ventilation.
This spontaneous prospective pregnancy report as received from a physician refers to a 23 years old female patient. The patient became pregnant with last menstrual period (LMP) of approximately 06-JUN-2015 and estimated delivery date (EDD) of approximately 12-MAR-2016. The patient had no concomitant medication, pertinent medical history and more known drug reactions or allergies. On 18-JUL-2015, the pregnant patient was vaccinated with the second dose of GARDASIL (strength, dose, route of administration, lot# and expiration date were not reported). No adverse effects were reported. Exposure to GARDASIL occurred at 6 gestational week. Additional information has been requested.
p/vax nose red;MD dx allergic urticaria;hx sz-allergy to sz meds;voice hoarse;no fever;hx hydrocephalus w/shunt & frequent sz;no sz p/shot;MD advised no further hep b for child;
Diarrhea day 1 Dizziness day 1 Cognitive haze day 1, 2, 3
positive case of COVID-19 7/26/2021 fever, sore throat, cough, chills, body aches, nasal congestion, illness lasted 2 weeks
following the 1st dose was a sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix and the only symptom she remembers following the 1st dose was a sore arm. The reporter did not consent to follow-up. For tolerance of 2nd dose refer case US2020217470.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020217470:same reporter
This spontaneous report was received from a nurse concerning multiple unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ orally, as prophylaxis (Strength, dose, lot # and expiration date were not reported), which experienced a temperature excursion of 22 Fahrenheit degrees for an unspecified timeframe. It was unknown if there were previous temperature excursions. Data logger was not involved. No adverse effects were reported. A product quality complaint was not involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1706USA007466: US-009507513-1707USA000721: US-009507513-1707USA000722: US-009507513-1707USA000724:
?Covid arm?. Rash and swelling around injection site 8 days after the vaccine.  Rash is red and splotchy. Roughly the size of a golf ball.
Pt received Moderna vaccines on 02/13/21 and 03/13/21. Pt was admitted to the rehab unit on 11/24/21. While admitted, pt developed a low-grade fever and was tested for COVID which came back positive.
Very high fever; Very weak; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 07Apr2021 at 15:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and COVID-19. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 15:00, 24 hours after vaccination, the patient experienced very high fever and became very weak. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events very high fever and very weak was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
A report has been received from a Health Professional concerning a 6 year old, female subject, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on 07-NOV-2014. It was reported that a child had received FLUMIST Quadrivalent at school and one week later at the healthy kids clinic 07-NOV-2014. The outcome of the event of a child received FLUMIST Quadrivalent at school and one week later at the healthy kids clinic is unkown. The report was considered to be non-serious.
Within approximately 15 minutes from administration of flu vaccine, employee reported new onset of chest pain with pain radiating down right arm (opposite arm of which vaccine was received).  Chest pain described as an "elephant sitting on chest".  Vaccination time was approximately 1010am, with symptom onset occurring requiring activation of EMS.  EMS called at 1030am for evaluation and treatment.  Employee brought to local ER for evaluation.
Immediately following the injection I got extremely hot and nauseous.  As the day progressed (11/30/21) I began to start to hurt all over and get really tired and the nauseousness just got worse.  On 12/1/21 I came to work and had the symptoms just get worse. I was so sick to my stomach and I have fibro and sarcoidosis that have both been in remission.  However throughout this day my fibro started hurting so bad I couldn't have anything touching my skin.  My sarc also was flared up, all my joints and appendages started swelling and I had a very difficult time walking.  I called my physician and left a message to see if I could get some prednisone to help me with the sarc and fibro adverse reactions.  On 12/2/21 I was not able to get out of bed due to these side effects.  I still did not hear back from my Dr until Friday and he was able to call in a script for prednisone and with this only was I able to get out of bed and walk.  I still had the nauseousness and headache as well as extremely sore through Saturday.  On Sunday I was still in some pain but I no longer had the nauseousness.  The prednisone has been helping alot with the pain which allowed me to be back to work today on Monday 12/6/21.
Swelling, redness and rash located at Hep A injection site, increasing in size and spreading down to elbow.  Reaction began 24 hours after injection.  Was seen in Immediate Care 3 days after injection.  Symptoms continue today and she will be seen in the office for further evaluation.
Immediately after 4th injection (HPV) Pt had stiffening of body, gluteral oral sound, fixed stare, then fainted. Vomited after recovery from faint. Was pale with faint pulse. After resting she recovered without incident.
Patient presneted to the ED and was subsequently hospitalized for NSTEMI on 3/24/21 as well as 4/12/21.
felt tired; shaking; whole body shivering; felt her body was very heavy; had a 101.2-103.1 fever; nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy), PYREXIA (had a 101.2-103.1 fever) and NAUSEA (nauseous) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013Az1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021 at 2:00 AM, the patient experienced TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy), PYREXIA (had a 101.2-103.1 fever) and NAUSEA (nauseous). On 04-Mar-2021 at 6:00 AM, the patient experienced FATIGUE (felt tired). On 04-Mar-2021, TREMOR (shaking), CHILLS (whole body shivering), LIMB DISCOMFORT (felt her body was very heavy) and PYREXIA (had a 101.2-103.1 fever) had resolved. On 04-Mar-2021 at 6:00 AM, NAUSEA (nauseous) had resolved. At the time of the report, FATIGUE (felt tired) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She took Tylenol for the fever.
Patient started experiencing signs and symptoms the next morning. Patient's left upper arm was red, swollen, hot, and itchy.
My period started almost less than 24 hours since my first vaccine and has not stopped since. It is almost 4 weeks on my period.
L lower neck swollen lymph node - painful. Rx with Ibuprofen, ice. Resolved 3 days later.
Lethargy, diarrhea, vomiting, fussiness, crying, fever.
Right arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right arm was sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right arm was sore). At the time of the report, PAIN IN EXTREMITY (Right arm was sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-085234 (Patient Link).
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 18-MAY-2016, the patient was vaccinated with an improperly stored dose of M-M-R II 0.5 ml injection, lot# L026553, expiration date: 16-JUL-2017, (route and site of administration were not reported). Concomitant therapies were not provided. According to the reporter, the vaccine was stored at a temperature of 11.1 Celsius degree for 1 hour and 36 minutes and also at a temperature of -12.3 Celsius degree for 1 hour and 33 minutes (excursion dates were not reported). No adverse symptoms were reported. No product quality complain (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Client reported shortness of breath and chest pain 2 weeks after receiving second Pfizer COID vaccine. She was transported to the hospital and received an EKG and a CT Scan of the chest. Patient reported that the scan showed lareg blood clots in both lungs. She reports that she was given high dose TPA and admitted to the ICU. Per client she had ultrasound of legs, arms, and groin which was negative. She is currently taking Eliquis and was discharged from the hospital on 4/6/2021.  #Hospital for 3 days
Itchy, red patch of swollen skin appeared a exactly 1 week after I had the 1st injection.  The area was approximately 2 inches in diameter.
Pt states rash and itching to lower extremeties 1 day after vaccination.  Continued to have symptoms for 2 weeks up until she used hydrocortisone cream 2 days ago which gave relief.
Patient reports unilateral right-sided weakness that occurred 2 hours after vaccines that last for 10-15 minutes, resolved, and then reoccurred 2 hours later. Reports feeling mentally foggy and with skin sensitivity, tingling and numbness on the right side (same side as vaccine) during both episodes.    Called EMS. Symptoms resolved by the time emergency services arrived.
UPON WAKING ON 10/3/15 HAD RASH ON LEFT ARM, FACE AND NECK.  RASH IS RED, RAISED, VERY ITCHY, EYES ITCH.  AS OF 10/9/15 PATIENT SEEN BY NP IN PCP OFFICE.  NOTES STATE FLU LIKE SYMPTOMS THE DAY AFTER RECEIVING THE SHOT TO INCLUDE MALAISE AND MILD NAUSEA.  NEXT DAY DEVELOPED A WIDESPREAD MACULAR PAPULAR RASH ON FACE, NECK, CHEST, ARMS AND ABDOMEN.  NOTES SUSPECT REACTION TO FLU SHOT AS IN PREVIOUS YEARS WHEN SHE RECEIVED THE VACCINATION SHE DEVELOPED RASH, ALTHOUGH NOT AS EXTENSIVE.  PER CCRNP. PATIENT WAS REFERRED TO ALLERGIST, PATIENT HAS APPOINTMENT SCHEDULED FOR 10/22/15.
Patient had difficulty speaking, then said he felt weird, then developed dyspnea and stridor.
Information has been received from a physician concerning a female who on 17-JUL-2007 was vaccinated with a dose of Gardasil. On 17-JUL-2007 the "patient received a dose of Gardasil and fainted. Unspecified medical attention was sought. Subsequently, the patient recovered. Additional information has been requested.
This spontaneous report was received from a certified medical assistant (C.M.A.) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not specified. On 11-JAN-2016, the patient was vaccinated with an improperly stored dose of M-M-R II (dose and route of administration were not provided) lot # L012479, expiry date 10-APR-2017. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Case number PHHY2012US099188 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 463810) on 01 Nov 2012. This report refers to 11-year-old male patient. The patient's medical history included chest congestion, wheezing, attention deficit hypersensitivity disorder, allergic rhinitis, migraines, mild persistent asthma, sleep disorder and oppositional disorder. The patient was vaccinated with MENVEO (batch number: M11082) intramuscularly in left arm on 29 Aug 2012. On 30 Aug 2012, after the vaccination, the patient experienced itching, redness, swelling, fever, hardness and pain at the injection site. The outcome of events was reported as condition unchanged as of 31 Aug 2012.
Immediately after first dose of vaccine patient developed worsening fatigue, exertional dyspnea, fever, cough, body aches. These symptoms persistent with profound pleuritic chest pain and limited exercise tolerance from January-May 2021. She just now has started to clinically improve. Work-up with small pleural and pericardial effusion. Extensive evaluation without alternative cause for symptoms.
Inflammation (red) about quarter size. Hot to touch and painful for patient. Itchy skin was hard to the touch.
Heart Palpitations; severe Angina was completely out of the norms; Heart Palpitations; severe Angina was completely out of the norms; Kidney Problem; This is a spontaneous report from a contactable consumer.   A 42-year- old male patient received  BNT162B2 (sPFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot no: EW0183), via unspecified route as dose 1, single, on on 18Jun2021 for COVID-19 immunisation.The patient had had Covid in Feb2020 and he sustained at the time that he had really severe kidney pain. The patient concomitant medication was not reported. On 18June2021, the patient stated that Within 3 hours of vaccination, he experienced heart palpitations raised, severe Angina because that completely out of the norms for him and he never had a heart problem that kind of result and he was in the Emergency Room of the Hospital  The patient was out of the Emergency Room by 10 o clock (18Jun2021) but now he has same kidney problem that he had half and Year ago, severe kidney pain. He had been experiencing that kidney issue all over again. When probed for any treatment for the problems (events), reporter stated, The local Hospital said to take Ibuprofen, lots of water and bed rest but he has not taken anything yet and also on Pedialyte Electrolyte. He was released from the Hospital at 10 o clock on 18Jun2021 because the heart palpitations and severe Angina resolved itself over about the period of about 4 hours. The outcome of events kidney pain was reported as unknown.  No follow-up attempts are possible. No further information is expected.